MAPT and Alzheimer disease: A unique genetic interaction between MAPT, GSK3B, and APOE ε4 was identified in patients with nHS-TLE, which differs from the genetic interaction between MAPT and APOE ε4 in patients with HS-TLE and patients with AD.